For many years, the standard approach for managing atherosclerotic carotid disease has focused primarily on measuring luminal stenosis, which is the degree of narrowing inside the artery [1]. However, histological and modern imaging studies reveal that plaques with identical degrees of stenosis can behave very differently [1]. Because medical therapy has continually improved, traditional metrics based solely on luminal narrowing are no longer entirely adequate for informing clinical decisions in patients with asymptomatic carotid stenosis [6]. Consequently, healthcare providers and researchers are shifting toward more advanced imaging strategies that evaluate the true composition and vulnerability of a plaque [1], [6].
Understanding what makes a carotid plaque dangerous is essential for modern stroke prevention. Ischemic strokes frequently stem from atheroembolism, where unstable plaques in the carotid bifurcation rupture and release debris into the bloodstream [3]. Plaque instability and subsequent rupture are typically driven by several key features: an enlarging lipid-rich necrotic core, active inflammation, fragile new blood vessels caused by hypoxia-induced angiogenesis, and intraplaque hemorrhage [3]. Intraplaque hemorrhage involves the accumulation of blood components directly within the plaque structure, while morphological factors like overall plaque thickness and surface ulceration also significantly elevate the risk of ischemic events [1].
Advanced diagnostic methods—including magnetic resonance imaging (MRI), specialized ultrasound, computed tomography, and positron emission tomography—allow clinicians to characterize these dangerous features in detail [1]. Among these modalities, magnetic resonance imaging provides exceptional insight into plaque composition and vulnerability [7]. While traditional ultrasound and duplex imaging assess overall plaque burden and echolucency [6], [8], or measure total plaque area and volume as strong predictors of cardiovascular risk [8], MRI offers superior visualization of soft tissue components. Specifically, MRI can detect critical elements like intraplaque hemorrhage and lipid cores that standard narrowing measurements miss entirely [1], [7].
Integrating detailed plaque imaging into clinical workflows supports more personalized risk stratification [3]. In asymptomatic patients, identifying high-risk plaque features helps tailor comprehensive strategies that combine lifestyle modifications with intensive medical therapies to address both cerebrovascular and general cardiovascular risks [2]. Furthermore, health economic evaluations suggest that utilizing advanced imaging strategies, such as assessing intraplaque hemorrhage with magnetic resonance, can optimize patient management pathways and improve long-term outcomes [7]. By treating the structural changes within the arteries rather than focusing solely on isolated risk factors [8], modern imaging helps clinicians better protect patients from potentially devastating ischemic events.
Sources
- [1] Carotid Plaque Composition and the Importance of Non-Invasive in Imaging Stroke Prevention. Frontiers in cardiovascular medicine, 2022.
- [2] Primary Stroke Prevention: Medical Therapy Versus Revascularization. Interventional cardiology clinics, 2014.
- [3] Carotid Plaque Instability and Cerebral Atheroembolism: Future Directions in Stroke-Prevention. Thrombosis and haemostasis, 2025.
- [4] The Role of Cardiac Imaging in Stroke Prevention. Cardiac electrophysiology clinics, 2014.
- [5] Carotid plaque burden across the glycaemic spectrum: a cross-sectional study. BMC endocrine disorders, 2026.
- [6] Moving beyond luminal stenosis: imaging strategies for stroke prevention in asymptomatic carotid stenosis. Cerebrovascular diseases (Basel, Switzerland), 2015.
- [7] Cost-effectiveness of magnetic resonance carotid plaque imaging for primary stroke prevention in Canada. The British journal of radiology, 2018.
- [8] Uses of ultrasound in stroke prevention. Cardiovascular diagnosis and therapy, 2020.